Sionna Therapeutics Prices Upsized Initial Public Offering
Sionna Therapeutics Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines ...
Sionna Therapeutics, Inc.: Sionna Therapeutics Prices Upsized Initial Public Offering
Sionna Therapeutics Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis ...
Semiconductor Engineering3h
Chip Industry Week In Review
Industry growth reports; new GF CEO; UVM for mixed signal; power demands explode; EU-US chip collaboration; earnings; S Korea ...
You Can Buy Rivian's Van, But Don't Come A Knockin' On RIVN, Analyst Warns
Rivian has made its all-electric commercial van available for sale to the general public after years of it being only ...
Arm Beats Earnings but Stock Is Falling Anyway. Here’s Why.
The company reported fiscal third-quarter adjusted earnings per share of 39 cents, compared with Wall Street’s consensus ...
Bloomberg L.P.18h
Goldman Sachs Momentum Builder Multi Asset 5 Index
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...